Nanomix Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $8.4M

Nanomix General Information

Description

Nanomix Corp develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or monitor diseases. Its products include The Nanomix eLab System, COVID-19 Rapid Antigen Panel, and Critical Infection and Host Response. The company's products improve healthcare delivery by bringing the diagnostic information to the point of initial patient interaction, whether in the hospital or settings such as nursing facilities, elderly homes, urgent care centers, airports, schools, and more.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 2121 Williams Street
  • San Leandro, CA 94577
  • United States
+1 (510)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 2121 Williams Street
  • San Leandro, CA 94577
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanomix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
21. PIPE 29-Jun-2021 $8.4M Completed Generating Revenue
20. Reverse Merger 04-Jun-2021 Completed Generating Revenue
19. Debt - PPP 27-Apr-2020 Completed Generating Revenue
18. Grant 08-Apr-2020 Completed Generating Revenue
17. Secondary Transaction - Private Completed Clinical Trials - General
16. Accelerator/Incubator 01-Jun-2019 Completed Clinical Trials - General
15. Later Stage VC (Series EE) 09-Nov-2017 Completed Clinical Trials - General
14. Later Stage VC (Series DD) 30-Jan-2014 Completed Clinical Trials - General
13. Later Stage VC (Series CC) 19-Aug-2011 $6.35M $56.9M Completed Clinical Trials - General
12. Later Stage VC (Series BB) 02-Aug-2010 $1.79M $50.6M Completed Clinical Trials - General
To view Nanomix’s complete valuation and funding history, request access »

Nanomix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series EE-2
Series EE-1
Series DD
Series CC
Series BB 22,120,639 $0.000010 $0.01 $0.08 $0.08 1x $0.08 17.2%
Series AA 1,045,650 $0.000010 $0.09 $1.15 $4.6 4x $1.15 0.81%
To view Nanomix’s complete cap table history, request access »

Nanomix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Nanomix Corp develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or monito
Diagnostic Equipment
San Leandro, CA
35 As of 2025

San Diego, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanomix Competitors (12)

One of Nanomix’s 12 competitors is ACON Laboratories, a Corporate Backed or Acquired company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACON Laboratories Corporate Backed or Acquired San Diego, CA
Illumina Formerly VC-backed San Diego, CA
Radiometer Medical Corporate Backed or Acquired Bronshoj, Denmark
Abbott Diagnostics Failed Transaction (M&A) Lake Forest, IL
Micropoint Formerly VC-backed Santa Clara, CA
You’re viewing 5 of 12 competitors. Get the full list »

Nanomix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanomix Acquisitions (1)

Nanomix’s most recent deal was a Merger/Acquisition with Boston Therapeutics. The deal was made on 04-Jun-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Boston Therapeutics 04-Jun-2021 Merger/Acquisition Pharmaceuticals
To view Nanomix’s complete acquisitions history, request access »

Nanomix ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Nanomix’s complete esg history, request access »

Nanomix FAQs

  • When was Nanomix founded?

    Nanomix was founded in 2000.

  • Where is Nanomix headquartered?

    Nanomix is headquartered in San Leandro, CA.

  • What is the size of Nanomix?

    Nanomix has 35 total employees.

  • What industry is Nanomix in?

    Nanomix’s primary industry is Diagnostic Equipment.

  • Is Nanomix a private or public company?

    Nanomix is a Private company.

  • What is Nanomix’s current revenue?

    The current revenue for Nanomix is .

  • How much funding has Nanomix raised over time?

    Nanomix has raised $86.3M.

  • Who are Nanomix’s competitors?

    ACON Laboratories, Illumina, Radiometer Medical, Abbott Diagnostics, and Micropoint are some of the 12 competitors of Nanomix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process